Scoring Key: 5=Strongly Agree 4=Agree 3=Neutral 2=Disagree 1=Strongly Disagree 0=Not applicable to my practice
Create an understanding of the rationale for this new treatment modality.
List physical and dosimetric advantages.
Differentiate integrative versus alternative use of healing modalities.
Discuss the differences between traditional versus evidence-based acupuncture.
Identify the concerns of undocumented and unsupervised use of supplements.
Discuss controversies in current breast cancer treatment options.
Assess future challenges in the management of breast cancer.
Explain the biological rationale behind dose-dense chemotherapy.
Summarize cumulative data in support of dose-dense chemotherapy.
Recognize the implications of the concept in the era of precision medicine.
Explain the criteria for genetic testing availability.
Discuss single-gene versus multi-gene approaches.
Assess new information regarding new genes, including screening recommendations when available.
Define and explain the meaning of variant uncertain significance (VUS).
Explain current guidelines and recommendations regarding screening mammograms.
Discuss the benefits of screening mammograms focusing on women starting at age 40.
Identify the role of additional imaging in screening for breast cancer.
Implement an algorithm for the screening of high-risk patients.
Assess the ongoing revolution in communication and how it influences thought patterns.
Explain the effects of computer use during doctor-patient interactions.
Identify the complex implications of changed communications in the precision medicine era.
Implement the use of adjuvant fat grating.
Identify nipple-sparing procedures in appropriate candidates.
Apply the use of stacked flaps and expanded flaps for low-BMI patients wanting autologous reconstructions.
Discuss the prevalence, phenomenology, risk factors and course of cancer-related cognitive impairment (CRCI).
Implement management and prevention strategies for CRCI.
Explain the pathophysiology of CRCI.
Scoring key: 5=Very effective, 4= Effective, 3= Somewhat effective, 2= Slightly effective, 1= Completely Ineffective Speakers are listed according to the lecture schedule.
Applications of Proton Therapy in Breast Cancer - Marcio Fagundes, M.D.
Integrative Oncology: Paradigm Shift - Yoon Hang “John” Kim, M.D., MPH
Breast Cancer 2017: Hot Topics, Controversies and Challenges - Jane E. Mendez, M.D.
Dose-Dense Chemotherapy: Does It Work and Why? - Larry Norton, M.D.
Hereditary Breast Cancer Syndrome - Arelis E. Martir-Negron, M.D.
Breast Imaging Update - Katharine Lampen-Sachar, M.D.
The Doctor-Patient Relationship in an Era of Precision Medicine - Larry Norton, M.D.
Advances in Autologous and Implant-Based Breast Reconstruction - Miguel A. Medina III, M.D.
Diagnosis, Pathophysiology and Management of Cancer-Related Cognitive Impairment - Beatriz B. Currier, M.D.